State Street Corp Vertex Pharmaceuticals Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 12,006,483 shares of VRTX stock, worth $5.47 Billion. This represents 0.23% of its overall portfolio holdings.
Number of Shares
12,006,483
Previous 12,083,818
0.64%
Holding current value
$5.47 Billion
Previous $4.92 Billion
2.08%
% of portfolio
0.23%
Previous 0.24%
Shares
17 transactions
Others Institutions Holding VRTX
# of Institutions
1,623Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$11.6 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10 Billion0.22% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.23 Billion1.08% of portfolio
-
Jpmorgan Chase & CO New York, NY6.02MShares$2.74 Billion0.23% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $117B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...